BUONFIGLIOLI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 2.295
EU - Europa 1.275
AS - Asia 678
AF - Africa 94
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.348
Nazione #
US - Stati Uniti d'America 2.287
GB - Regno Unito 411
CN - Cina 238
SE - Svezia 228
SG - Singapore 203
DE - Germania 159
IT - Italia 129
VN - Vietnam 125
IN - India 81
IE - Irlanda 77
RU - Federazione Russa 67
FR - Francia 47
UA - Ucraina 41
EE - Estonia 39
ZA - Sudafrica 37
TG - Togo 30
BG - Bulgaria 24
CI - Costa d'Avorio 18
JO - Giordania 15
CH - Svizzera 14
BE - Belgio 12
GR - Grecia 9
CA - Canada 8
NG - Nigeria 7
FI - Finlandia 6
IR - Iran 5
KR - Corea 4
NL - Olanda 4
AU - Australia 3
CZ - Repubblica Ceca 2
JP - Giappone 2
LB - Libano 2
MK - Macedonia 2
PL - Polonia 2
SC - Seychelles 2
BR - Brasile 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
PH - Filippine 1
SI - Slovenia 1
TW - Taiwan 1
Totale 4.348
Città #
Southend 379
Fairfield 330
Chandler 237
Singapore 174
Ashburn 169
Woodbridge 146
Houston 124
Seattle 121
Wilmington 116
Santa Clara 105
Ann Arbor 101
Dong Ket 96
Cambridge 83
Princeton 79
Boardman 78
Dublin 77
Westminster 40
Bologna 37
Nanjing 32
Lomé 30
Medford 27
Bremen 26
New York 25
Saint Petersburg 25
Sofia 24
Dearborn 23
Padova 23
Florence 20
Abidjan 18
Berlin 17
Falls Church 16
Amman 15
San Diego 14
Beijing 12
Brussels 12
Jacksonville 12
Jinan 12
Shenyang 12
Bern 11
Pune 11
Changsha 10
Hebei 9
Milan 9
Turin 9
Guangzhou 8
Jiaxing 8
Shanghai 8
Tianjin 8
Abeokuta 7
Des Moines 7
Helsinki 6
Toronto 6
Fuzhou 5
Monmouth Junction 5
Nanchang 5
Norwalk 5
Redmond 5
Redwood City 5
Zhengzhou 5
Ardabil 4
Haikou 4
Hangzhou 4
Moscow 4
Wuhan 4
Xi'an 4
Buffalo 3
Gangnam-gu 3
Imola 3
Kunming 3
Leawood 3
Ningbo 3
Taizhou 3
Arlington 2
Falkenstein 2
Groningen 2
Kiev 2
Mahé 2
Olalla 2
Pittsburgh 2
Qingdao 2
Shenzhen 2
Skopje 2
Spezzano della Sila 2
Suzhou 2
Taicang 2
Tokyo 2
Ulan-ude 2
Verona 2
Washington 2
Amsterdam 1
Andover 1
Anyang 1
Asti 1
Athens 1
Augusta 1
Baoding 1
Bari 1
Casalecchio di Reno 1
Chengdu 1
Cologno Monzese 1
Totale 3.129
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 187
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 175
Adverse effects of proton pump inhibitors. 161
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 149
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 146
Alisporivir for the treatment of chronic HCV 144
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 138
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 131
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 127
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 123
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 122
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 114
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 113
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 111
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 111
null 107
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 105
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 103
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 99
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 99
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 99
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 98
null 96
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 96
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 94
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 93
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 93
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 91
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 91
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 91
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 86
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 85
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 84
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 75
null 70
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 68
Outcomes and survival after TIPS positioning: a single center experience 68
Outcomes and survival after TIPS positioning: a single center experience 66
null 65
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 54
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 50
Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD) 31
Lamivudine treatment for severe acute HBV hepatitis. 23
Totale 4.462
Categoria #
all - tutte 11.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020565 0 0 0 0 0 0 145 142 123 61 44 50
2020/2021485 104 43 29 5 3 8 7 25 72 32 25 132
2021/2022886 94 24 36 54 69 43 12 47 24 39 303 141
2022/2023879 86 120 52 133 58 86 21 43 155 18 65 42
2023/2024269 9 47 8 22 15 90 10 16 26 5 11 10
2024/2025533 54 152 99 52 139 37 0 0 0 0 0 0
Totale 4.462